DiagnoCure


Their main aim is commercialization of molecular diagnostics for the detection and management of cancer.
Their target is "detection, diagnosis and management of cancer." DiangoCure offers molecular diagnostic tests that show you particularities in genes connected with cancer. This company was established in 1994, DiagnoCure commercialized its first diagnostic test, ImmunoCyt™ / uCyt+™ for bladder cancer, in Europe in 1998.
Business Type: Nanotextile » | Biotechnology » | Electrotechnics » |
DiagnoCure4535 Wilfrid-Hamel Blvd, Suite 250 |
Share with friends:
Next companies in category
Nanotechnology in medicine | Nano materials | Nanotechnology electronics | Nano asociation |
Follow Nanotechnology Journal on
© 2008 - 2021 Nanotechnology research | All rights reserved | Developed by Makovic.net